| Literature DB >> 32502976 |
Nadeem R Abu-Rustum1, Catheryn M Yashar2, Sarah Bean3, Kristin Bradley4, Susana M Campos5, Hye Sook Chon6, Christina Chu7, David Cohn8, Marta Ann Crispens9, Shari Damast10, Christine M Fisher11, Peter Frederick12, David K Gaffney13, Robert Giuntoli14, Ernest Han15, Warner K Huh16, John R Lurain Iii17, Andrea Mariani18, David Mutch19, Christa Nagel20, Larissa Nekhlyudov5, Amanda Nickles Fader21, Steven W Remmenga22, R Kevin Reynolds23, Rachel Sisodia24, Todd Tillmanns25, Stefanie Ueda26, Renata Urban27, Emily Wyse28, Nicole R McMillian29, Angela D Motter29.
Abstract
The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma.Entities:
Mesh：
Year: 2020 PMID： 32502976 DOI： 10.6004/jnccn.2020.0027
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908